Filing Flows

Filing Flows › Companies › Intelligent Bio Solutions › Cash flow

Intelligent Bio Solutions cash flow, quarter by quarter

Latest: Q4 FY26 · from the cash-flow statements filed with the SEC

Free cash flow−$3.2M in Q4 FY26

Operating cash flow−$3.2M
Free cash flow−$3.2M

Analysis

In Q4 FY26, Intelligent Bio Solutions generated −$3.2M of operating cash flow. That is $972K less than in Q4 FY25 (−$2.2M).

Operating cash flow was −$3.2M against net income of −$3.9M. The largest differences: depreciation & amortization +$288K, prepaid and other assets −$188K, inventory +$179K.

Free cash flow

Intelligent Bio Solutions: free cash flow by quarterIntelligent Bio Solutions: free cash flow by quarter−$2.4MQ1 FY25−$2.3MQ2 FY25−$2.8MQ3 FY25−$2.2MQ4 FY25−$2.9MQ1 FY26−$1.6MQ2 FY26−$4.3MQ3 FY26−$3.2MQ4 FY26
Operating cash flow less capital spending.
Intelligent Bio Solutions: operating cash flow against capital spendingIntelligent Bio Solutions: operating cash flow against capital spendingOperating cash flowCapital spending−$2.4M$0Q1 FY25−$2.3M$0Q2 FY25−$2.8M$0Q3 FY25−$2.2M$0Q4 FY25−$2.8M$70KQ1 FY26−$1.6M$68KQ2 FY26−$4.3M−$13KQ3 FY26−$3.2M$0Q4 FY26
Latest (Q4 FY26): Operating cash flow −$3.2M, Capital spending $0.

Capital allocation, year by year

Intelligent Bio Solutions: where the cash came from (up) and went (down), by fiscal yearIntelligent Bio Solutions: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedAsset salesCapital spendingAcquisitionsFY22: Operating cash flow −$3.4MFY22FY23: Operating cash flow −$7.4MFY23: Shares issued $221KFY23: Acquisitions −$364K$221KFY23FY24: Operating cash flow −$9.6MFY24: Capital spending −$221KFY24FY25: Operating cash flow −$9.7MFY25: Capital spending −$232KFY25FY26: Operating cash flow −$11.9MFY26: Asset sales $40KFY26: Capital spending −$126K$40KFY26
Over these 5 years operating cash flow totalled −$41.9M; the largest uses were operating cash flow ($41.9M) and capital spending ($579K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$4.0M
Debtnone
Net cash$4.0M
Cash runway4 months

Intelligent Bio Solutions is burning cash: its operations consume cash, a free cash flow of −$12.7M a year at the current rate against $4.0M of cash and investments: a runway of about 4 months before any new financing.

Where the cash came from and went

Intelligent Bio Solutions: sources (+) and uses (−) of cash, Q4 FY26Intelligent Bio Solutions: sources (+) and uses (−) of cash, Q4 FY26Operating cash flow−$3.2MCash drawn (+) / kept (−)$2.9MOther financing$312KExchange rates$427

From profit to cash

Intelligent Bio Solutions: net income to operating cash flow, Q4 FY26Intelligent Bio Solutions: net income to operating cash flow, Q4 FY26Net income−$3.9MDepreciation & amortization$288KStock-based pay$97KReceivables$30KInventory$179KPrepaid and other assets−$188KOther liabilities$9KOperating cash flow−$3.2M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 FY2657102676-518
Q2 FY2660128869-680
Q1 FY265498661-509
Q3 FY2539161279-80
Q2 FY2552172348-123
Q1 FY2546133310-131

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q4 FY26−$3.2M——$2.9M−$3.2M
Q3 FY26−$4.3M$13K—−$6.1M−$4.3M
Q2 FY26−$1.6M−$68K—$920K−$1.6M
Q1 FY26−$2.8M−$70K—−$640K−$2.9M
Q4 FY25−$2.2M——$1.8M−$2.2M
Q3 FY25−$2.8M—$810K−$565K−$2.8M
Q2 FY25−$2.3M—$642K$1.7M−$2.3M
Q1 FY25−$2.4M—$35K$2.3M−$2.4M

Intelligent Bio Solutions: income statement and cash flow

Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%. The chart follows the revenue to costs, profit and cash.

Intelligent Bio Solutions: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.